课题基金 / 基金详情

ATHE ANTI-IDIOTYPE ANTIBODY APPROACH FOR AN HIV VACCINE

ATHE ANTI-IDIOTYPE ANTIBODY APPROACH FOR AN HIV VACCINE
HIV 疫苗的抗独特型抗体方法
批准号:
3506179
负责人:
KANDASAMY HARIHARAN
金额:
$25.0万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-15 至 1994-08-31

项目摘要

项目成果

KANDASAMY HARIHARAN的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,我们建议继续开发抗独特型(anti-id)。
英文摘要
In this study we propose to continue to develop an anti-idiotype (anti-id) -based strategy for eliciting and/or boosting broadly neutralizing antibodies against HIV. The principle of this approach is based on clonotypic stimulation which utilizes anti-id as surrogate for antigen in an attempt to stimulate specific elements of the B cell repertoire in humans. In phase I of this study, one anti-id Mab (3C9) was identified which induced broadly neutralizing anti-gp12O antibodies in immunonaive monkeys. Our studies will be extended to identify the utility of 3C9 to boosting titers of broadly neutralizing anti-gp12O antibodies. This aim will be achieved by determining the immunogenicity of 3C9 when tested in HIV-infected individuals and gp120 immune monkeys. In parallel, our efforts will continue to develop new anti-id Mabs which may be superior to 3C9 with respect to their potential as both prophylactic and therapeutic vaccines. We will generate anti-id Mabs which interact with the most prevalent, broadly neutralizing antibodies in the sera of HIV-infected individuals and vaccinated volunteers. These anti-id Mabs will be tested to determine whether they are capable of inducing and boosting the anti-gp12O titer in naive and gp12O primed cynomolgus monkeys. By comparing these results with that of 3C9, we will define new anti-id Mabs for clinical studies. In practice, the anti-id Mabs could be used as a therapy for HIV+ individuals and a prophylactic vaccine when combined with gp12O immunizations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THERAPEUTIC ANTICD23 ANTIBODY DIMERS FOR CLL
  • 批准号:
    2868017
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    1999
  • 负责人:
    KANDASAMY HARIHARAN
  • 依托单位:
海外基金